BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific

  Under the five-year agreement, Thermo Fisher will manufacture Gimoti for Evoke’s potential commercial efforts.

  November 9, 2017

   · 

  4 min read
• Business

  SQI Diagnostics to Announce Fourth Quarter and Fiscal 2017 Results

  President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, November 17, 2017 at 10:00 a.m. ET to review financial results and discuss business developments for the period.

  November 9, 2017

   · 

  2 min read
• Decisions of Herantis Pharma Plc’s Extraordinary General Meeting of Shareholders

  The Extraordinary General Meeting of Shareholders resolved to authorise the Board of Directors, as proposed by the Board of Directors, to decide on the issuance of shares.

  November 9, 2017

   · 

  2 min read
• MR Solutions Receives Scientific Recognition With Institute of Physics Award

  The award was presented by the President of the Institute, Professor Dame Julia Higgins at a formal awards dinner presentation held on 7 November, 2017.

  November 9, 2017

   · 

  2 min read
• Business

  Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance

  The company reported fourth quarter and full-year fiscal 2017 net revenues of $49.7 million and $200.8 million.

  November 9, 2017

   · 

  17 min read
• Deals

  Karolinska Development Will Receive Shares in Pharmanest AB

  Karolinska Development AB today announces that the company will receive 140,149 shares in Pharmanest AB. Furthermore, the company will receive 11,527 shares via KCIF Co-Investment Fund.

  November 9, 2017

   · 

  2 min read
• Drug Development

  Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at Action Duchenne

  The data show that continuously expressing utrophin in a dystrophin-deficient background can reduce mitochondrial aberration and oxidative stress.

  November 9, 2017

   · 

  6 min read
• Genetown

  IDBS Takes Bioprocess Execution Solution to the Cloud

  IDBS announces the release of its latest Bioprocess Execution (BPES) informatics solution. Leveraging the IDBS E-WorkBook Cloud platform.

  November 9, 2017

   · 

  2 min read
• Deals

  Telix Pharmaceuticals Limited Successfully Completes $50M Oversubscribed Initial Public Offering

  The IPO was strongly supported by institutional investors internationally and domestically, as well as by retail investors in Australia.

  November 9, 2017

   · 

  2 min read
• Drug Development

  Prima BioMed: New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting

  The data will be presented in the poster titled “Pushing the accelerator and releasing the brake: testing the soluble LAG-3 protein (IMP321).

  November 9, 2017

   · 

  3 min read